TOP HEADLINES

Featured Story

  • U.K. health secretary: Novartis holding government to 'ransom' with Bexsero pricing

    Earlier this month, U.K. politicians asked Prime Minister David Cameron to explain why Novartis' Bexsero, approved as an addition to the country's childhood immunization schedule 8 months back, had yet to be covered by the National Health Service. Now, Cameron has asked Health Secretary Jeremy Hunt to do the same--and Hunt is pointing the finger at the Swiss pharma.

Bloomberg: NewLink, Merck in Ebola vaccine production talks

To scale up production of its Ebola vaccine, NewLink Genetics is going to need some manufacturing help. And for that, it's reportedly in talks with vaccine giant Merck.

Themis, Institut Pasteur expand collaboration on solid PhI Chikungunya results

Themis Bioscience and the Institut Pasteur have good news to report from a Phase I trial of their Chikungunya fever vaccine candidate. And the pair thinks its successful results just might lead to advances in other diseases, too.

India's Cipla breaks into vaccines with Serum deal in Europe

Indian generics maker Cipla is taking its low-cost game into the vaccine field, thanks to a new deal with the Serum Institute of India.

PATH chooses Mymetics for work on transmission-blocking malaria vaccine

With a brand-new $156 million Gates Foundation grant in hand, the PATH Malaria Vaccine Initiative has signed on Switzerland-based Mymetics to develop and produce virosome-based vaccine formulations for a malaria transmission-blocking vaccine candidate.

U.K. health secretary: Novartis holding government to 'ransom' with Bexsero pricing

Earlier this month, U.K. politicians asked Prime Minister David Cameron to explain why Novartis' Bexsero, approved as an addition to the country's childhood immunization schedule 8 months back, had yet to be covered by the National Health Service. Now, Cameron has asked Health Secretary Jeremy Hunt to do the same--and Hunt is pointing the finger at the Swiss pharma.

MORE NEWS

From Our Sister Sites

FierceDiagnostics

LabCorp and CareDx have officially pulled the plug on a previously announced agreement to develop a lupus flare predictor test after completing the first phase of their collaboration.

FierceAnimalHealth

A U.K. consortium led by Zoetis announced a $3 million project that will use visual imaging and digital technology to improve the health and wellness of pig herds with a goal of better production.